Titan Pharmaceuticals Inc (NAS:TTNP)
$ 4.1 0.13 (3.27%) Market Cap: 3.75 Mil Enterprise Value: -2.50 Mil PE Ratio: 0 PB Ratio: 0.94 GF Score: 40/100

Q1 2020 Titan Pharmaceuticals Inc Earnings Call Transcript

May 15, 2020 / 04:00PM GMT
Release Date Price: $165 (-19.14%)
Operator

Good day, everybody, and thank you for holding. Welcome to the Titan Pharmaceuticals First Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be archived on the company's website starting later today.

At this time, I would like to hand the conference over to Sunil Bhonsle, President and CEO of Titan Pharmaceuticals. Please go ahead.

Sunil Bhonsle
Titan Pharmaceuticals, Inc. - President, CEO, Principal Financial Officer & Director

Thank you, Eric, and thank you all for joining us. Welcome to the Titan Pharmaceuticals call to review financial and operational results for the first quarter ended March 31, 2020, and provide an update on our business.

It's been only 6 weeks since the last call at the end of March, but with the changing environment we have encountered, these have been very busy indeed. Before we begin, I wanted to inform you that we have filed our quarterly report on Form 10-Q with the SEC and the press release issued

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot